Kosteneffektivität von Screening auf Amblyopie

Neubauer, A. S.; Neubauer, Stefan

doi:10.1055/s-2004-813905

Cited by 11 publications

(9 citation statements)

References 15 publications

(19 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The main limitation of the early Konig and Barry papers, 159,162,163 and the other German studies, 166,167 is that they do not facilitate the evaluation of screening programmes based at alternative ages. Moreover, they do not describe the effects of identifying the target conditions for the screening programmes.…”

Section: Discussion Of Economic Studiesmentioning

confidence: 99%

“…Of 11 identified economic papers, seven were published by the same German research team, seemingly led by Konig and Barry. [159][160][161][162][163][164][165] Two other separate German studies were identified, 166,167 and also two US-based studies.…”

Section: Review Of Previous Economic Analyses Of Screening For Amblyopiamentioning

confidence: 99%

“…159,162,163 Another German evaluation estimated the cost per QALY gained from amblyopia screening based on a very simple formula, where QALYs gained were estimated as the product of the test sensitivity, treatment effectiveness and a utility decrement (of 0.08) over the remainder of affected children's lives (60 years). 167 Joish 168 evaluated screening children at 6-18 months, 3-4 years or 7-8 years. A decision tree described progression through this programme to describe true and false negatives, and true and false positives.…”

Section: ;169mentioning

confidence: 99%

See 2 more Smart Citations

The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4-5 years: a systematic review and economic evaluation

Carlton¹,

Karnon²,

Czoski-Murray³

et al. 2008

Health Technol Assess

149

162

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTAThe clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4-5 years: a systematic review and economic evaluation NIHR Health Technology Assessment ProgrammeT he Health Technology Assessment (HTA) Programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care. The research findings from the HTA Programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service'. The HTA Programme is needs-led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projects. First is the commissioned rout...

show abstract

Section: Discussion Of Economic Studiesmentioning

confidence: 99%

Section: Review Of Previous Economic Analyses Of Screening For Amblyopiamentioning

confidence: 99%

Section: ;169mentioning

confidence: 99%

See 1 more Smart Citation

The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4-5 years: a systematic review and economic evaluation

Carlton¹,

Karnon²,

Czoski-Murray³

et al. 2008

Health Technol Assess

149

162

View full text Add to dashboard Cite

show abstract

“…48 • Concerns about bullying of children, especially with eye patching, at school leading to poor compliance 51 further support earlier treatment of amblyopia, i.e., prior to school entry. 52 The Screening Program • Screening for amblyopia is cost-effective; 53 universal eye examination for preschool children has a low cost per QALY. 8 • The location of the screening program is likely to affect uptake.…”

Section: The Treatmentmentioning

confidence: 99%

Childhood Vision Screening in Canada: Public Health Evidence and Practice

Mema

McIntyre

Musto

2012

Can J Public Health

View full text Add to dashboard Cite

creening is an important public health strategy for disease prevention. It enables the early identification of disease in asymptomatic individuals and allows them to benefit from direct preventive action. 1 Preschool vision screening has been used for the early detection of amblyopia or lazy eye, which is the leading cause of monocular blindness in the 20 to 70 year age group in higher-income countries. 2 Amblyopia is defined as reduced visual acuity (VA) with no obvious structural or pathologic causes that cannot be improved by corrective lenses. 3 The condition develops within the first six years of life, 4 and once established, persists. Many countries have well-established amblyopia screening programs. 5 In Sweden, for example, children beginning at age 4 are assessed for VA by public health nurses in a program that has an uptake of over 99%. 6 Historically, Canadian public health efforts routinely targeted early detection of amblyopia with trained public health nurses, 7 but a 2007 report 8 showed wide variation in amblyopia screening practices among Canadian provinces. The decline of amblyopia screening seems to be attributed to reservations about the level of evidence that exists to justify such programming. 9 Evidence-Based Medicine (EBM), a concept embraced in clinical practice, privileges evidence derived from randomized controlled trials. 10 In the case of amblyopia screening, a Cochrane systematic review of the literature stated that "despite the large amount of literature available regarding vision screening no trials designed to compare the prevalence of amblyopia in screened versus unscreened populations were found" (ref. 11, pg. 1). This review 11 and a second systematic review 5 both concluded that there was insufficient evidence on the impact of vision screening. The lack of evidence from randomized controlled trials about amblyopia screening has been interpreted as lack of evidence in support of screening, with the result that data from cohort studies and natural experiments, which have shown benefits from screening, have been ignored. In addition, little consideration has been given to whether amblyopia fulfills the World Health Organization's principles for screening 12 (Table 1). We suggest that an Evidence-Based Public Health (EBPH) approach might better bridge evidence and practice in the case of amblyopia screening. 10 EBPH offers a decision-making framework based on research evidence as well as the population characteristics and resources available, and directs policy-makers to accept the 'best available' as opposed to the 'best possible' evidence. 10 In this paper, we review the evidence underlying amblyopia screening

show abstract

“…Die Behandlung der Amblyopie mit Okklusion stellt seit Jahrzehnten eine etablierte Methode dar. Der Nutzen der Okklusionsbehandlung liegt vor allem in der Vermeidung von Kosten, die entstehen, wenn Patienten mit unzureichend behandelter Amblyopie im Laufe des Lebens ihr gutes Auge verlieren [15]. Der Zeitraum, den ein solcher Patient beidseitig sehbehindert (Visus beidseits > 0,3 logMAR) verbringt, verlängert sich etwa von 8 auf 15 1 / 2 Monate [9].…”

unclassified

Visusevaluierung in einer historischen Kohorte von 137 okkludierten Patienten, 30 - 35 Jahre nach Ende der Okklusionsbehandlung

Simonsz-Tòth¹,

Loudon²,

Saar³

et al. 2007

Klin Monatsbl Augenheilkd

View full text Add to dashboard Cite

show abstract

Kosteneffektivität von Screening auf Amblyopie

Abstract: Screening for amblyopia meets the basic requirements of cost-effectiveness.

Cited by 11 publications

References 15 publications

The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4-5 years: a systematic review and economic evaluation

The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4-5 years: a systematic review and economic evaluation

Childhood Vision Screening in Canada: Public Health Evidence and Practice

Visusevaluierung in einer historischen Kohorte von 137 okkludierten Patienten, 30 - 35 Jahre nach Ende der Okklusionsbehandlung

Contact Info

Product

Resources

About